Accès ouvert
2025
article
OpenAlex
Charlotte van Ginkel, Cléo Baars, Dorien M. Tiemessen, Cornelius F.J. Jansen et autres
Disruption of the glycosaminoglycan (GAG)-layer and urothelial barrier is an important aspect of the pathophysiology of bladder pain syndrome/ interstitial cystitis. Intravesical hyaluronic acid (HA) is often used in treatments for IC/BPS, however the role in the urothelial barrier is unknown. This …
nl
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Cléo Baars, Charlotte van Ginkel, John P.F.A. Heesakkers, Mathilde Scholtes et autres
BACKGROUND: Interstitial cystitis/bladder pain syndrome (IC/BPS) patients are more susceptible to urinary tract infections (UTIs), likely worsening pre-existing symptoms. However, this receives limited attention in guidelines. This study aimed to explore the burden of UTIs on IC/BPS patients' quality of life and …
nl
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Floris M. Thunnissen, Cléo Baars, Rianne Arts, Carmen S. S. Latenstein et autres
BACKGROUND: Laparoscopic cholecystectomy is the gold standard for treating biliary colic in patients with gallstones, but post-cholecystectomy abdominal pain is commonly reported. This study investigates which symptoms are likely to persist and which may develop after a cholecystectomy. METHODS: Patients from 2 …
nl, us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Aida Javan Balegh Marand, Cléo Baars, John P.F.A. Heesakkers, Ellen H. A. van den Munckhof et autres
INTRODUCTION: It has been hypothesized that the urinary microbiome might play an important role in OAB. Studies have been conducted on the association between OAB symptoms and the microbiome, although a possible causality still has to be determined. MATERIAL AND METHODS: In …
nl, ir
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Charlotte van Ginkel, Cléo Baars, John P.F.A. Heesakkers, Frank M. J. Martens et autres
INTRODUCTION: Obtaining level 1 evidence on efficacy of glycosaminoglycan (GAG) therapy is difficult, due to low incidence of bladder pain syndrome/interstitial cystitis (BPS/IC) and heterogeneous symptoms experienced by patients with BPS/IC. Currently, because of a lack of high-grade evidence, the recommendation for …
nl
(code pays fourni par la source)